Intriguingly, there was a downregulation of the m6A level in primary AML blasts with NPM1 mutations compared with those without NPM1 mutations or the healthy donor sample by m6A dot blot assays (Figure 1A). Here, NPM1 is linked to acute myeloid leukemia.